NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
24 hedge funds and large institutions have $226K invested in Navidea Biopharmaceuticals Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30K | |
| 2 | +$24K | |
| 3 | +$17.5K | |
| 4 |
ACM
Allred Capital Management
Dallas,
Texas
|
+$15.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.4K |
Top Sellers
| 1 | -$11.6K | |
| 2 | -$2.49K | |
| 3 | -$920 | |
| 4 |
JPMorgan Chase & Co
New York
|
-$165 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$10 |